The interaction of hepatitis B virus X protein and protein phosphatase type 2 Cα and its effect on IL-6

Biochemical and Biophysical Research Communications

Volumn 351, Issue 1, 2006, Pages 253-258

  Kim, Ji Su ^a   Rho, Bo young ^a   Lee, Tae Ho ^b   Lee, Jae Myun ^a   Kim, Se Jong ^a   Park, Jeon Han ^a  

^a Institute for Immunology and Immunological Diseases   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

HBx; Hepatocellular carcinoma; IL 6; PP2C

Indexed keywords

ENZYME; HEPATITIS B VIRUS X PROTEIN; INTERLEUKIN 6; PHOSPHOPROTEIN PHOSPHATASE 2 CALPHA; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TWO HYBRID SYSTEM;

CELL LINE; CELL PROLIFERATION; HEPATOCYTES; HUMANS; INTERLEUKIN-6; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; SIGNAL TRANSDUCTION; VIRAL REGULATORY PROTEINS;

ADENOVIRIDAE; HEPATITIS B VIRUS;

EID: 33750316808     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.10.028     Document Type: Article

References (24)

1. Cromlish J.A. Hepatitis B virus-induced hepatocellular carcinoma: possible roles for HBx. Trends Microbiol. 4 (1996) 270-274
2. Yen T.S. Hepadnaviral X protein: review of recent progress. J. Biomed. Sci. 3 (1996) 20-30
3. Diao J., Garces R., and Richardson C.D. X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis. Cytokine Growth Factor Rev. 12 (2001) 189-205
4. Su Q., Schroder C.H., Hofmann W.J., Otto G., Pichlmayr R., and Bannasch P. Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology 27 (1998) 1109-1120
5. Sehgal P.B. Regulation of IL6 gene expression. Res. Immunol. 143 (1992) 724-734
6. Coskun U., Bukan N., Sancak B., Gunel N., Ozenirler S., Unal A., and Yucel A. Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions. Neoplasma 51 (2004) 209-213
7. Lee Y., Park U.S., Choi I., Yoon S.K., Park Y.M., and Lee Y.I. Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells. Clin. Cancer Res. 4 (1998) 1711-1717
8. Hirano T., Ishihara K., and Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19 (2000) 2548-2556
9. Waris G., Huh K.W., and Siddiqui A. Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol. Cell Biol. 21 (2001) 7721-7730
10. Cohen P. The structure and regulation of protein phosphatases. Annu. Rev. Biochem. 58 (1989) 453-508
11. Ofek P., Ben-Meir D., Kariv-Inbal Z., Oren M., and Lavi S. Cell cycle regulation and p53 activation by protein phosphatase 2C alpha. J. Biol. Chem. 278 (2003) 14299-14305
12. Zhang X., Blenis J., Li H.C., Schindler C., and Chen-Kiang S. Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science 267 (1995) 1990-1994
13. Boudreau R.T., Hoskin D.W., and Lin T.J. Phosphatase inhibition potentiates IL-6 production by mast cells in response to FcepsilonRI-mediated activation: involvement of p38 MAPK. J. Leukoc. Biol. 76 (2004) 1075-1081
14. Yun C., Lee J.H., Park H., Jin Y.M., Park S., Park K., and Cho H. Chemotherapeutic drug, adriamycin, restores the function of p53 protein in hepatitis B virus X (HBx) protein-expressing liver cells. Oncogene 19 (2000) 5163-5172
15. Fields S., and Song O. A novel genetic system to detect protein-protein interactions. Nature 340 (1989) 245-246
16. Kim J., Chwae Y.J., Kim M.Y., Choi I.H., Park J.H., and Kim S.J. Molecular basis of HLA-C recognition by p58 natural killer cell inhibitory receptors. J. Immunol. 159 (1997) 3875-3882
17. Takai A., and Mieskes G. Inhibitory effect of okadaic acid on the p-nitrophenyl phosphate phosphatase activity of protein phosphatases. Biochem. J. 275 Pt. 1 (1991) 233-239
18. Choi Y.H., Kim H.I., Seong J.K., Yu D.Y., Cho H., Lee M.O., Lee J.M., Ahn Y.H., Kim S.J., and Park J.H. Hepatitis B virus X protein modulates peroxisome proliferator-activated receptor gamma through protein-protein interaction. FEBS Lett. 557 (2004) 73-80
19. Chan D.W., and Ng I.O. Knock-down of hepatitis B virus X protein reduces the tumorigenicity of hepatocellular carcinoma cells. J. Pathol. 208 (2006) 372-380
20. Kakumu S., Shinagawa T., Ishikawa T., Yoshioka K., Wakita T., and Ida N. Interleukin 6 production by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection and primary biliary cirrhosis. Gastroenterol. Jpn. 28 (1993) 18-24
21. Tangkijvanich P., Vimolket T., Theamboonlers A., Kullavanijaya P., Suwangool P., and Poovorawan Y. Serum interleukin-6 and interferon-gamma levels in patients with hepatitis B-associated chronic liver disease. Asian Pac. J. Allergy Immunol. 18 (2000) 109-114
22. Bromberg J.F., Wrzeszczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., and Darnell Jr. J.E. Stat3 as an oncogene. Cell 98 (1999) 295-303
23. Klumpp S., Selke D., Ahlemeyer B., Schaper C., and Krieglstein J. Relationship between protein phosphatase type-2C activity and induction of apoptosis in cultured neuronal cells. Neurochem. Int. 41 (2002) 251-259
24. Watanabe S., Mu W., Kahn A., Jing N., Li J.H., Lan H.Y., Nakagawa T., Ohashi R., and Johnson R.J. Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cells. Am. J. Nephrol. 24 (2004) 387-392